Events & Presentations

Investors

Events & Presentations

Upcoming Events
Date Event Details Remind Me
Sep 4, 2019 9:40 AM EDT
Baird's 2019 Global Healthcare Conference
New York, NY
Sep 5, 2019
Citi’s 14th Annual Biotech Conference
Boston, MA
Sep 16, 2019 11:00 AM +04
Global Summit On Cardiology & Heart Diseases
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver a keynote presentation titled, “Treating hypertriglyceridemic states with RNA interference – emergence of an exciting new modality to treat cardiovascular diseases”
Dubai, UAE
Oct 18, 2019 8:00 AM EDT
Arrowhead Analyst R&D Day 2019
New York, NY
Archived Events
Date Event Details
Aug 12, 2019
BTIG Biotechnology Conference 2019
New York, NY
Aug 5, 2019 4:30 PM EDT
Arrowhead Pharmaceuticals 2019 Third Quarter Results
Jul 17, 2019
Roth RNA Revolution Conference
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, and Vincent Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in panel discussions.
Jun 21, 2019
Alpha-1 National Conference
Orlando, FL
James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “ARO-AAT for Liver Disease in Alpha-1 Antitrypsin Deficiency: Progress in Clinical Development”
Jun 8, 2019 2:30 PM +08
Science of HBV Cure 2019
Singapore
Bruce Give, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver an oral presentation titled, “RNAi: Pulling Us Toward Finite Therapy”
Jun 6, 2019 9:30 AM EDT
Jefferies 2019 Global Health Care Conference
New York, NY
Vincent Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in a fireside chat presentation with Maury Raycroft, Ph.D., Jefferies research analyst
May 23, 2019 8:30 AM PDT
20ᵀᴴ Annual B. Riley FBR Institutional Investor Conference
Beverly Hills
Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will participate in a fireside chat presentation with Mayank Mamtani, B. Riley FBR research analyst
May 18, 2019 11:25 AM EDT
2019 National Lipid Association Scientific Sessions
Aventura, FL

So Wong, Ph.D., Arrowhead’s director of biology, will deliver a poster presentation titled, “Personalized Medicine for Dyslipidemias by RNA Interference-Mediated Reductions in Apolipoprotein C3 or Angiopoietin-Like Protein 3”

May 15, 2019 8:40 AM PDT
Bank of America Merrill Lynch 2019 Health Care Conference
Las Vegas, Nevada
Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will deliver a corporate presentation
May 15, 2019 11:00 AM EDT
Vascular Discovery: From Genes to Medicine 2019 Scientific Sessions (ATVB|PVD)
Boston

So Wong, Ph.D., Arrowhead’s director of biology, will deliver a poster presentation titled, “Reduction in Angiopoietin-Like Protein 3 via RNA Interference Improves Dyslipidemias and Hepatic Steatosis”